APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Live Attenuated Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 2032

28 December 202571 pages

Choose your research edition.

Industry ResearchOral Live Attenuated Rotavirus Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Oral Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Live Attenuated Rotavirus Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oral Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, Lanzhou Biological Products Research Institute, GSK and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Live Attenuated Rotavirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Live Attenuated Rotavirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Live Attenuated Rotavirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Live Attenuated Rotavirus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Live Attenuated Rotavirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Live Attenuated Rotavirus Vaccine Market by Company

Merck Sharp & Dohme

Lanzhou Biological Products Research Institute

GSK

Bharat Biotech

Oral Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Oral Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics

Vaccination Sites

Oral Live Attenuated Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Live Attenuated Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Live Attenuated Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monovalent Vaccines Table 2. Major Company of Combination Vaccines Table 3. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Oral Live Attenuated Rotavirus Vaccine Industry Trends Table 25. Oral Live Attenuated Rotavirus Vaccine Industry Drivers Table 26. Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges Table 27. Oral Live Attenuated Rotavirus Vaccine Industry Restraints Table 28. Global Oral Live Attenuated Rotavirus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Oral Live Attenuated Rotavirus Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Oral Live Attenuated Rotavirus Vaccine Sales Share by Company (2021-2026) Table 32. Global Oral Live Attenuated Rotavirus Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Oral Live Attenuated Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral Live Attenuated Rotavirus Vaccine Major Company Production Sites and Headquarters Table 35. Global Oral Live Attenuated Rotavirus Vaccine Company, Product Type & Application Table 36. Global Oral Live Attenuated Rotavirus Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral Live Attenuated Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral Live Attenuated Rotavirus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Sharp & Dohme Company Information Table 72. Merck Sharp & Dohme Business Overview Table 73. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 75. Merck Sharp & Dohme Recent Development Table 76. Lanzhou Biological Products Research Institute Company Information Table 77. Lanzhou Biological Products Research Institute Business Overview Table 78. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 80. Lanzhou Biological Products Research Institute Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 85. GSK Recent Development Table 86. Bharat Biotech Company Information Table 87. Bharat Biotech Business Overview Table 88. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 90. Bharat Biotech Recent Development Table 91. North America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 93. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 94. North America Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 96. North America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Oral Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 99. North America Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Oral Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 101. Europe Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 103. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 104. Europe Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Oral Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 109. Europe Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Oral Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 119. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 121. Latin America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 123. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 124. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Oral Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 129. Latin America Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Oral Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 139. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Oral Live Attenuated Rotavirus Vaccine Distributors List Table 144. Oral Live Attenuated Rotavirus Vaccine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Oral Live Attenuated Rotavirus Vaccine Image Figure 2. Global Oral Live Attenuated Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Live Attenuated Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Live Attenuated Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Monovalent Vaccines Image Figure 6. Global Monovalent Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Vaccines Image Figure 8. Global Combination Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Oral Live Attenuated Rotavirus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral Live Attenuated Rotavirus Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals and Clinics Image Figure 24. Global Hospitals and Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Vaccination Sites Image Figure 26. Global Vaccination Sites Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Oral Live Attenuated Rotavirus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oral Live Attenuated Rotavirus Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Oral Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oral Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Oral Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oral Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oral Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oral Live Attenuated Rotavirus Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oral Live Attenuated Rotavirus Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Hospitals and Clinics
  • Vaccination Sites
Companies covered
  • Merck Sharp & Dohme
  • Lanzhou Biological Products Research Institute
  • GSK
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Live Attenuated Rotavirus Vaccine Market by Type
  6. 1.3.1 Monovalent Vaccines
  7. 1.3.2 Combination Vaccines
  8. 1.4 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  9. 1.4.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral Live Attenuated Rotavirus Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral Live Attenuated Rotavirus Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Live Attenuated Rotavirus Vaccine Industry Trends
  2. 2.2 Oral Live Attenuated Rotavirus Vaccine Industry Drivers
  3. 2.3 Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral Live Attenuated Rotavirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Live Attenuated Rotavirus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Live Attenuated Rotavirus Vaccine Price (2021-2026)
  4. 3.4 Global Oral Live Attenuated Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Live Attenuated Rotavirus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Live Attenuated Rotavirus Vaccine Company, Product Type & Application
  7. 3.7 Global Oral Live Attenuated Rotavirus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Live Attenuated Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Live Attenuated Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Oral Live Attenuated Rotavirus Vaccine Regional Status and Outlook
  1. 4.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Live Attenuated Rotavirus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Live Attenuated Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Live Attenuated Rotavirus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Oral Live Attenuated Rotavirus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Live Attenuated Rotavirus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Live Attenuated Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Live Attenuated Rotavirus Vaccine by Application
  1. 5.1 Oral Live Attenuated Rotavirus Vaccine Market by Application
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Vaccination Sites
  4. 5.2 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  5. 5.2.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Live Attenuated Rotavirus Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Live Attenuated Rotavirus Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck Sharp & Dohme
  2. 6.1.1 Merck Sharp & Dohme Company Information
  3. 6.1.2 Merck Sharp & Dohme Business Overview
  4. 6.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  6. 6.1.5 Merck Sharp & Dohme Recent Developments
  7. 6.2 Lanzhou Biological Products Research Institute
  8. 6.2.1 Lanzhou Biological Products Research Institute Company Information
  9. 6.2.2 Lanzhou Biological Products Research Institute Business Overview
  10. 6.2.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  12. 6.2.5 Lanzhou Biological Products Research Institute Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bharat Biotech
  20. 6.4.1 Bharat Biotech Company Information
  21. 6.4.2 Bharat Biotech Business Overview
  22. 6.4.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  24. 6.4.5 Bharat Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country
  2. 7.1.1 North America Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 7.2.1 North America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country
  2. 8.1.1 Europe Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 8.2.1 Europe Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Live Attenuated Rotavirus Vaccine Sales by Country
  2. 10.1.1 South America Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 10.2.1 South America Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Live Attenuated Rotavirus Vaccine Value Chain Analysis
  2. 12.1.1 Oral Live Attenuated Rotavirus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Live Attenuated Rotavirus Vaccine Production Mode & Process
  7. 12.2 Oral Live Attenuated Rotavirus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Live Attenuated Rotavirus Vaccine Distributors
  10. 12.2.3 Oral Live Attenuated Rotavirus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst